| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Research Services, Tucson and Overton Brooks Veterans Affairs Medical Centers, and Department of Medicine, University of Arizona, Tucson, Arizona 85723; 2 Department of Molecular and Cellular Physiology, Louisiana State University Medical Center, Shreveport, Louisiana 71131; and 3 The First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan
Peroxynitrite, an oxidant generated by the interaction between superoxide and nitric oxide (NO), can nitrate tyrosine residues, resulting in compromised protein function. Monocyte chemoattractant protein-1 (MCP-1) is a chemokine that attracts monocytes and has a tyrosine residue critical for function. We hypothesized that peroxynitrite would alter MCP-1 activity. Peroxynitrite attenuated MCP-1-induced monocyte chemotactic activity (MCA) in a dose-dependent manner (P < 0.05) but did not attenuate leukotriene B4 or complement-activated serum MCA. The reducing agents dithionite, deferoxamine, and dithiothreitol reversed the MCA inhibition by peroxynitrite, and exogenous L-tyrosine abrogated the inhibition by peroxynitrite. PAPA-NONOate, an NO donor, or superoxide generated by xanthine and xanthine oxidase did not show an inhibitory effect on MCA induced by MCP-1. The peroxynitrite generator 3-morpholinosydnonimine caused a concentration-dependent inhibition of MCA by MCP-1. Peroxynitrite reduced MCP-1 binding to monocytes and resulted in nitrotyrosine formation. These findings are consistent with nitration of tyrosine by peroxynitrite, with subsequent inhibition of MCP-1 binding to monocytes, and suggest that peroxynitrite may play a role in regulation of MCP-1-induced monocyte chemotaxis.
nitric oxide; monocyte migration; superoxide; nitrotyrosine; monocyte chemoattractant protein-1
This article has been cited by other articles:
|
|
 |
|
  J. L. Freels, D. K. Nelson, J. C. Hoyt, M. Habib, H. Numanami, R. C. Lantz, and R. A. Robbins Enhanced Activity of Human IL-10 After Nitration in Reducing Human IL-1 Production by Stimulated Peripheral Blood Mononuclear Cells J. Immunol., October 15, 2002; 169(8): 4568 - 4571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wassmann, S. Hilgers, U. Laufs, M. Bohm, and G. Nickenig Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1208 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, A. Panoskaltsis-Mortari, M. Shukla, B. R. Blazar, and I. Y. Haddad Exuberant Inflammation in Nicotinamide Adenine Dinucleotide Phosphate-Oxidase-Deficient Mice After Allogeneic Marrow Transplantation J. Immunol., June 1, 2002; 168(11): 5840 - 5847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. ANDERS, V. VIELHAUER, M. KRETZLER, C. D. COHEN, S. SEGERER, B. LUCKOW, L. WELLER, H.-J. GRÖNE, and D. SCHLÖNDORFF Chemokine and Chemokine Receptor Expression during Initiation and Resolution of Immune Complex Glomerulonephritis J. Am. Soc. Nephrol., May 1, 2001; 12(5): 919 - 931. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
